QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

PRE

QT70Prenetics Global Limited
NASDAQ·Healthcare·Medical - Diagnostics & Research·Hong Kong
Latest market price
20.50
+0.64+3.22%
OverviewShort InterestFilings
PREQT70Prenetics Global Limited·NASDAQ
OverviewShort InterestFilings
20.50+3.22%
TA
Loading chart...
Screen all →
TMO+0.63%$464.61DHR-0.33%$177.17IDXX+2.93%$562.09A+2.20%$127.06NTRA+2.19%$231.41IQV-1.70%$167.77ILMN+1.79%$161.93WAT-0.44%$355.44
Snapshot
Index-P/E-EPS (ttm)-4.58
Insider Own6.05%
Shs Outstand17.14M
Perf Week-0.92%
Market Cap337.54MForward P/E-EPS next Y-0.55Insider Trans0.28%Shs Float-Perf Month40.22%
Enterprise Value281.98MPEG0.23EPS next Q-Inst Own-Short Float-Perf Quarter-3.07%
Income-71120264.00P/S2.97EPS this Y30.70%Inst Trans-Short Ratio-Perf Half Y23.64%
Sales113.75MP/B2.78EPS next Y82.80%ROA-40.52%Short Interest-Perf YTD30.16%
Book/sh9.39P/C-EPS next 5Y-ROE-46.74%52W High23.63 -13.25%Perf Year172.97%
Cash/sh1.40P/FCF-EPS past 3/5Y-ROIC-25.54%52W Low7.05 190.78%Perf 3Y-
Dividend Est.-EV/EBITDA-5.46Sales past 3/5Y91.99% 7.20%Gross Margin58.32%Volatility4.14% 5.61%Perf 5Y-
Dividend TTM-EV/Sales2.48EPS Y/Y TTM-Oper. Margin-33.69%ATR (14)1.55Perf 10Y-
Dividend Ex-DateFeb 17, 2016Quick Ratio4.60Sales Y/Y TTM270.97%Profit Margin-62.45%RSI (14)55.33Recom2.00
Dividend Gr. 3/5Y-35.09% -21.51%Current Ratio5.15EPS Q/Q-SMA203.54%Beta0.88Target Price36.00
Payout0.00%Debt/Eq0.00Sales Q/Q111.76%SMA5012.38%Rel Volume0.61Prev Close19.86
Employees285LT Debt/Eq0.02Earnings-SMA20024.49%Avg Volume231.63KPrice20.50
IPO DateJul 16, 2021Option/ShortYes / YesEPS/Sales Surpr.-Net Debt/EBITDA1.08Volume140,303Change3.22%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-11-26InitiatedRoth CapitalBuy$36
Latest News
Jun-16-26
Jun-16-2609:11AM
Benchmark Initiates Coverage On Prenetics Global with Buy Rating, Announces Price Target of $30Benzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
Total Revenue1159231
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A484415
Gross Profit664915
Selling, General and Administrative Excl. Other968055
Research and Development4511
Other Operating Expense42-2
Operating Income-38-38-48
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)18-29
Net Income Before Taxes-73-36-58
Income Taxes00-8
Consolidated Net Income-70-38-46
Net Income From Continuing Operations-73-36-50
Net Income-70-38-46
EPS (Recurring)-4.58-2.68-3.64
EPS (Basic, Before Extraordinaries)-4.58-2.68-3.64
EPS (Diluted)-4.58-2.68-3.64
EBITDA-53-32-52
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio3.032.40—
Gross Margin57.3953.2648.39
Operating Margin-33.04-41.30-154.84
Net Margin-60.87-41.30-148.39
Shares Outstanding171413
Market Capitalization349221—
Operating Lease Expense
———
Insider Trading Volume
$21.59$19.73$17.86$15.99$14.13● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
VANDERVEEN DAVIDDirectorJun 15 '26Option Exercise0.0015,625045,249Jun 16 12:00 AM
Cheng Yin PanDirectorJun 15 '26Option Exercise0.0031,746059,051Jun 16 12:00 AM
Desmet LaurieEVP & COO, PartnerRe LtdDec 21 '15Sale139.1171098,77038,386Dec 22 12:00 AM
SAUTTER REMYDirectorSep 17 '15Option Exercise71.1210,564751,31224,866Sep 18 12:00 AM
SAUTTER REMYDirectorSep 17 '15Sale138.465,282731,33919,584Sep 18 12:00 AM
SAUTTER REMYDirectorSep 16 '15Option Exercise69.3831,2262,166,30630,352Sep 18 12:00 AM
SAUTTER REMYDirectorSep 16 '15Sale138.4615,6132,161,84419,584Sep 18 12:00 AM
ZWIENER DAVID KPresident & CEO PartnerRe Ltd.Jun 15 '15Option Exercise65.251,956127,62924,003Jun 17 12:00 AM
SAUTTER REMYDirectorJun 15 '15Option Exercise48.951,56576,60417,668Jun 17 12:00 AM
MONTUPET JEAN PAUL LDirectorJun 15 '15Option Exercise48.931,81989,00117,054Jun 17 12:00 AM
MENDOZA ROBERTO GDirectorJun 15 '15Option Exercise65.252,594169,2598,808Jun 17 12:00 AM
Walker Theodore CPresident & CEO, PartnerRe NAFeb 05 '15Option Exercise60.2836,6292,208,12035,866Feb 09 12:00 AM
Walker Theodore CPresident & CEO, PartnerRe NAFeb 05 '15Sale121.062,874347,93332,992Feb 09 12:00 AM
Desmet LaurieEVP & COO, PartnerRe LtdFeb 05 '15Option Exercise47.753,204153,00030,126Feb 06 12:00 AM
Clarke EmmanuelCEO, PartnerRe GlobalFeb 04 '15Option Exercise51.7014,491749,17545,887Feb 06 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR